May 3, 2007 - CMS, Inc., is currently testing and set to release Monaco, its next-generation Intensity Modulated Radiotherapy Treatment (IMRT) planning system, which in addition to a conventional dose-based optimization platform, will offer a biological model for more accurate and precise planning to account for tissue and volume-specific dose tolerances.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now